BE VACCINES PTE LIMITED — Vaccine Importer Profile
Pharmaceutical Importer · #17 buyer for Vaccine · $671.6K import value · 14 shipments · MALI · DGFT Verified
BE VACCINES PTE LIMITED is the #17 importer of Vaccine from India with $671.6K in import value and 14 verified shipments. BE VACCINES PTE LIMITED holds a 0.1% market share in Vaccine imports based in MALI. The company sources from 1 verified supplier across 3 formulations shipped to 11 countries.
BE VACCINES PTE LIMITED — Vaccine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vaccine to BE VACCINES PTE LIMITED?
Verified from 14 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BIOLOGICAL E LIMITED | $671.6K | 14 | 100.0% |
BE VACCINES PTE LIMITED sources Vaccine from 1 verified Indian supplier based on 14 customs records. The primary supplier is BIOLOGICAL E LIMITED accounting for 100.0% of imports.
Where Does BE VACCINES PTE LIMITED Import Vaccine To?
Destination countries from 14 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALI | $150.0K | 3 | 22.3% |
| KENYA | $100.0K | 2 | 14.9% |
| SIERRA LEONE | $50.0K | 1 | 7.4% |
| MAURITANIA | $50.0K | 1 | 7.4% |
| PAKISTAN | $50.0K | 1 | 7.4% |
| ANGOLA | $50.0K | 1 | 7.4% |
| BANGLADESH | $50.0K | 1 | 7.4% |
| LESOTHO | $50.0K | 1 | 7.4% |
| BURKINA FASO | $50.0K | 1 | 7.4% |
| SUDAN | $50.0K | 1 | 7.4% |
BE VACCINES PTE LIMITED imports Vaccine to 11 countries. The primary destination is MALI receiving 22.3% of shipments worth $150.0K.
What Vaccine Formulations Does BE VACCINES PTE LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| S359348 MR VACCINE MEASLES AND RUBELLA | $521.6K | 11 |
| S359349 MR VACCINE MEASLES AND RUBELLA | $100.0K | 2 |
| S359348 MR VACCINE MEASLES AND RUBELLA V | $50.0K | 1 |
BE VACCINES PTE LIMITED imports 3 distinct Vaccine formulations from India. The top formulation is S359348 MR VACCINE MEASLES AND RUBELLA with 11 shipments worth $521.6K.
Who Are the Top Buyers of Vaccine from India and How Much Does BE VACCINES PTE LIMITED Import?
India exported $38.1M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. BE VACCINES PTE LIMITED imports $671.6K of this total, accounting for 0.1% of India's Vaccine exports with 14 shipments from MALI. This is verified from 14 customs shipment records covering 3 distinct formulations.
What Is the Average Order Value for BE VACCINES PTE LIMITED's Vaccine Imports?
BE VACCINES PTE LIMITED's average Vaccine order value is $48.0K per consignment, based on 14 shipments totaling $671.6K. BE VACCINES PTE LIMITED is based in MALI and ranks #17 among all Vaccine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Vaccine to BE VACCINES PTE LIMITED?
BE VACCINES PTE LIMITED sources Vaccine from 1 verified Indian supplier: BIOLOGICAL E LIMITED ($671.6K, 100.0%). This is based on 14 customs records.
How Does BE VACCINES PTE LIMITED Compare to Other Vaccine Importers?
BE VACCINES PTE LIMITED ranks #17 among 2,202 Vaccine importers from India with a 0.1% market share. The top 3 importers are NATIONAL PRIMARY HEALTH CARE ($6.3M), UNICEF SUPPLY DIVISION ($5.0M), MINISTRY OF HEALTH ($4.5M). BE VACCINES PTE LIMITED processed 14 shipments from MALI.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BE VACCINES PTE LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BE VACCINES PTE LIMITED's capped import value divided by total capped export value for Vaccine across all Indian exporters.
- 5.Verified Records: This page is backed by 14 individual customs records matching BE VACCINES PTE LIMITED importing Vaccine, covering 3 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Import Data for BE VACCINES PTE LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for BE VACCINES PTE LIMITED's Vaccine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BE VACCINES PTE LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
BE VACCINES PTE LIMITED × Vaccine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BE VACCINES PTE LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current order-level data, contact TransData Nexus.